Marizyme, Inc.
MRZM
$0.0003
-$0.0078-96.30%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 32.90K | 150.60K | 181.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 32.90K | 150.60K | 181.50K |
| Cost of Revenue | -- | 0.00 | 11.60K | 55.80K | 64.00K |
| Gross Profit | -- | 0.00 | 21.30K | 94.80K | 117.50K |
| SG&A Expenses | 902.10K | 1.16M | 962.70K | 7.55M | 4.27M |
| Depreciation & Amortization | 108.80K | 121.30K | 108.80K | 210.30K | 210.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.36M | 1.59M | 1.40M | 8.20M | 5.04M |
| Operating Income | -1.36M | -1.59M | -1.37M | -8.05M | -4.86M |
| Income Before Tax | -1.96M | -6.61M | -6.23M | -9.77M | -26.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.96M | -6.61M | -6.23M | -9.77M | -26.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.96M | -6.61M | -6.23M | -9.77M | -26.55M |
| EBIT | -1.36M | -1.59M | -1.37M | -8.05M | -4.86M |
| EBITDA | -1.25M | -1.47M | -1.26M | -7.84M | -4.65M |
| EPS Basic | -0.01 | -0.05 | -0.05 | -0.19 | -0.58 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.03 | 0.04 | -0.28 |
| EPS Diluted | -0.01 | -0.05 | -0.05 | -0.19 | -0.58 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.03 | 0.04 | -0.28 |
| Average Basic Shares Outstanding | 131.79M | 131.79M | 131.79M | 52.08M | 45.81M |
| Average Diluted Shares Outstanding | 131.79M | 131.79M | 131.79M | 52.08M | 45.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |